A Peptidic Binding Site Model for PDE 4 Inhibitors

Abstract

Selective inhibitors of the isoenzyme phosphodiesterase 4 (PDE 4) have attracted increased interest in the last few years as potential drugs for the treatment of allergic diseases such as asthmal,2.